|
Delayed
London S.E.
05:42:16 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 6.300 GBX | +3.28% |
|
+34.04% | -36.04% |
| 08-28 | WINNERS & LOSERS: McBride rises on deal win; Watkin Jones slumps | AN |
| 08-28 | Shield Therapeutics to Take Over US Commercialization of ACCRUFeR | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SHIELD THERAPEUTICS PLC | Biopharmaceuticals | +3.28% | +34.04% | -36.04% | -7.35% | -86.00% | 88.44M |  |  | |
- Stock Market
- Stocks
- STX Stock
- Charts Shield Therapeutics plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
